Dr. Renny Feldman has over 15 years of expertise in the biopharmaceutical industry, with experience in antibody and biologics-based drug discovery, immunology, biochemistry, and protein engineering. He obtained his PhD from the California Institute of Technology and joined Charles River in 2021 as a Science Director, to support the growth of large molecule capabilities and partnerships across the organization. He is currently the Head of Large Molecule Research for our South San Francisco Antibody Discovery site, the legacy Distributed Bio location.
Renny Feldman, PhD
Site Head and Director of Antibody Discovery